Dr. Borodovsky and his group develop machine learning algorithms for computational analysis of biological sequences: DNA, RNA and proteins. Our primary focus is on prediction of protein-coding genes and regulatory sites in genomic DNA. Probabilistic models play an important role in the algorithm framework, given the probabilistic nature of biological sequence evolution.

Andreas (Andy) S. Bommarius is a professor of Chemical and Biomolecular Engineering as well of Chemistry and Biochemistry at the Georgia Institute of Technology in Atlanta, GA.  He received his diploma in Chemistry in 1984 at the Technical University of Munich, Germany and his Chemical Engineering B.S. and Ph.D. degrees in 1982 and 1989 at MIT, Cambridge, MA.

From 1990-2000, he led the Laboratory of Enzyme Catalysis at Degussa (now Evonik) in Wolfgang, Germany, where his work ranged from immobilizing homogenous catalysts in membrane reactors to large-scale cofactor-regenerated redox reactions to pharma intermediates.

At Georgia Tech since 2000, his research interests cover green chemistry and biomolecular engineering, specifically biocatalyst development and protein stability studies.  His lab applies data-driven protein engineering to improve protein properties on catalysts ranging from ene and nitro reductases to cellobiohydrolases.  Bommarius has guided the repositioning of the curriculum towards Chemical and Biomolecular Engineering by developing new courses in Process Design, Biocatalysis and Metabolic Engineering, as well as Drug Design, Development, and Delivery (D4), an interdisciplinary course with Mark Prausnitz.

Andy Bommarius in 2008 became a Fellow of the American Institute of Medical and Biological Engineering.  Since 2010, he is Director of the NSF-I/UCR Center for Pharmaceutical Development (CPD), a Center focusing on process development, drug substance and product stability, and novel analytical methods for the characterization of drug substances and excipients.

Saad Bhamla studies biomechanics across species to engineer knowledge and tools that inspire curiosity.

Saad Bhamla is an assistant professor of biomolecular engineering at Georgia Tech. A self-proclaimed "tinkerer," his lab is a trove of discoveries and inventions that span biology, physics and engineering. His current projects include studying the hydrodynamics of insect urine, worm blob locomotion and ultra-low-cost devices for global health. His work has appeared in the New York Times, the Economist, CNN, Wired, NPR, the Wall Street Journal and more.

Saad is a prolific inventor and his most notable inventions includes a 20-cent paper centrifuge, a 23-cent electroporator, and the 96-cent hearing aid. Saad's work is recognised by numerous awards including a NIH R35 Outstanding Investigator Award, NSF CAREER Award, CTL/BP Junior Faculty Teaching Excellence Award, and INDEX: Design to Improve Life Award. Saad is also a National Geographic Explorer and a TED speaker. Newsweek recognized Saad as 1 of 10 Innovators disrupting healthcare.

Saad is a co-founder of Piezo Therapeutics.

Outside of the lab, Saad loves to go hiking with his partner and two dogs (Ollie and Bella).

Dr. Jianhua Xiong is an Assistant Professor of Urology at Emory University School of Medicine. The laboratory investigates the metabolic regulation of cell fate and function, with a focus on urological disorders and cancer. Research explores how fatty acids influence cell behavior in T cells, endothelial cells, and cancer cells. A multidisciplinary approach integrates cell and molecular biology, biochemistry, super-resolution imaging, transcriptomics, proteomics, metabolomics, histology, tissue studies, and mouse models to understand cellular mechanisms and identify potential therapeutic strategies.

Dr. Gary W. Liu is an Assistant Professor of Biomedical Engineering at Georgia Institute of Technology and Emory School of Medicine. He received his B.S. in Biomedical Engineering from The University of Texas at Austin, and his Ph.D. in Bioengineering from the University of Washington, Seattle. He conducted his postdoctoral fellowship at Massachusetts Institute of Technology. Dr. Liu's research and mentorship have been recognized by the following: Ruth L. Kirschstein NRSA, K99/R00 Pathway to Independence Award, Excellence in Mentorship Award, and nomination for the Peter Karches Mentorship Prize. His research group seeks to develop new diagnostics and therapeutics for kidney medicine.

Dr. Johnna S. Temenoff is the Carol Ann and David D. Flanagan Professor at the Coulter Department of Biomedical Engineering at Georgia Tech/Emory University. She is also currently the Director of the NSF Engineering Research Center in Cell Manufacturing Technologies (CMaT) and the Director of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Scientifically, Dr. Temenoff is interested in scaling culture of therapeutic cells and tailoring the molecular interactions between glycosaminoglycans and proteins/cells for use in regenerative medicine applications.  Her laboratory focuses primarily on promoting repair after injuries to the tissues of the shoulder, including cartilage, tendon, and muscle.

Dr. Temenoff has been honored with several prestigious awards, such as the NSF CAREER Award, Arthritis Foundation Investigator Award, and Society for Biomaterials (SFB) Clemson Award for Contributions to the Literature, and was named to the College of Fellows of the American Institute for Medical and Biological Engineers (AIMBE), as a Fellow of the Biomedical Engineering Society (BMES), as a Fellow of the International Academy of Medical and Biological Engineering (IAMBE) and as a Fellow of Biomaterials Science and Engineering, International Union of Societies for Biomaterials Science and Engineering (IUSBSE).  She has co-authored a highly successful introductory textbook - Biomaterials: The Intersection of Biology and Materials Science, by J.S. Temenoff and A.G. Mikos (now in a 2nd edition), for which Dr. Temenoff and Dr. Mikos were awarded the American Society for Engineering Education’s Meriam/Wiley Distinguished Author Award for best new engineering textbook. 

Professor Wysocki received her bachelor of science in Chemistry at Western Kentucky University in 1982 and her Ph.D. in Chemistry at Purdue University in 1987.
Wysocki did her postdoc work at the Naval Research Laboratory as a National Research Council fellow Virginia Commonwealth University. She became an Assistant Professor in 1990 and an Associate Professor in 1994.
Wysocki went to the University of Arizona in 1996, was promoted to Professor in 2000, and served as Chair of the Department of Chemistry and Biochemistry.
From 2012 to 2024, Wysocki was an Ohio Eminent Scholar, Director of the Campus Chemical Instrument Center, and Professor in the Department of Chemistry and Biochemistry at the Ohio State University.
On Oct. 1, 2024, she became Professor and Chair of the School of Chemistry and Biochemistry at the Georgia Institute of Technology.
   
   Major awards
   2022 International Mass Spectrometry Foundation Thomson Medal,
   2022 ACS Analytical Division Chemical Instrumentation award,
   2017 ACS Field and Franklin Award,
   2009 ASMS Distinguished Contribution Award

Vision is energy-intensive. Mutations that impair a person's ability to generate energy disproportionately affect vision. Common diseases that cause blindness may also be related to a failure of the eye to generate sufficient energy to serve its needs. Our goal is to understand the metabolic function of individual cells in visual tissues, primarily the retina and retinal pigment epithelium. We want to know which cells in the eye carry out particular metabolic processes (glycogen synthesis, nucleotide synthesis, etc.), what causes a cell to be metabolically 'wired' as it is, the extent to which retina generates metabolic intermediates de novo vs. from circulating, and the extent to which neurodegenerative diseases such as age-related macular degeneration and glaucoma are linked to metabolic impairments.

Dr. Dickson is the Vassar Woolley Professor of Chemistry & Biochemistry and has been at Georgia Tech since 1998. He was a Senior Editor of The Journal of Physical Chemistry from 2010-2021, and his research has been continuously funded (primarily from NIH) since 2000. Dr. Dickson has developed quantitative bio imaging and signal recovery/modulation schemes for improved imaging of biological processes and detection of medical pathologies. His work on fluorescent molecule development and photoswitching of green fluorescent proteins was recognized as a key paper for W.E. Moerner’s 2014 Nobel Prize in Chemistry. Recently, Dr. Dickson’s lab has developed rapid susceptibility testing of bacteria causing blood stream infections. Their rapid recovery methods, coupled with rigorous multidimensional statistics and machine learning have led to very simple, highly accurate and fast methods for determining the appropriate treatment within a few hours after positive blood cultures. These hold significant potential for drastically improving patient outcomes and reducing the proliferation of antimicrobial resistance.